Purpose: to evaluate the safety and tolerability of a potential new drug for the purpose of treating various strains of influenza.
Participate in a clinical study of a potential treatment for influenza.
This study has 1 screening appointment, Day 1, 4 week follow up, and 6 month follow up.
Participants will dose 1 time in this study over 6 months.
Reimbursement for study participation will be provided for time and travel of up to $550.
This study has been reviewed by an Institutional Review Board.
Call 612-315-6490 to discuss your eligibility today!